Viewing Study NCT03136666


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-01-02 @ 4:55 AM
Study NCT ID: NCT03136666
Status: COMPLETED
Last Update Posted: 2017-05-02
First Post: 2017-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-04-19
Start Date Type: ACTUAL
Primary Completion Date: 2010-06-07
Primary Completion Date Type: ACTUAL
Completion Date: 2010-06-07
Completion Date Type: ACTUAL
First Submit Date: 2017-04-28
First Submit QC Date: None
Study First Post Date: 2017-05-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-04-28
Last Update Post Date: 2017-05-02
Last Update Post Date Type: ACTUAL